Skip to content

Neuronetics STIM Quick ratio

Quick ratio at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
1.5×0.0×
LBR
LB Pharmaceuticals Inc Common StockLBRX
35.7×
Stereotaxis logo
StereotaxisSTXS
1.1×+0.4×
Neuropace, Inc. logo
Neuropace, Inc.NPCE
4.3×-1.4×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
2.9×-0.2×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
4.9×+1.4×

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Calculated from Neuronetics’s reported figures.

Based on the most recent quarter.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's quick ratio?
Neuronetics (STIM) reported quick ratio of 1.5× in Q1 2026.
How has Neuronetics's quick ratio changed year-over-year?
Neuronetics's quick ratio decreased by 34.1% year-over-year, from 2.3× to 1.5×.
What is the long-term trend for Neuronetics's quick ratio?
Over 5 years (2020 to 2025), Neuronetics's quick ratio has grown at a -16.0% compound annual growth rate (CAGR), from 4.5× to 1.9×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.